To identify the potential role of IL-35+ B cells and other Breg subsets, we analyzed the percentages of circulating IL-35+ B cells, IL-10+ B cells, and CD5+ Bregs between newly diagnosed SLE patients and HCs by flow cytometry (Fig. 1A). The gene discussed is CD5; the disease is systemic lupus erythematosus.